Страна: Австралия
Язык: английский
Источник: APVMA (Australian Pesticides and Veterinary Medicines Authority)
MYCOPLASMA HYOPNEUMONIDE BACTERIN; THIOMERSAL
VIRBAC (AUSTRALIA) PTY LTD
vaccine - Mycoplasma hyopneum.
MISC. VACCINES OR ANTI SERA
MYCOPLASMA HYOPNEUMONIDE BACTERIN VACCINE-GENERAL Active 0.0 P; THIOMERSAL MERCURY Other 0.1 mg/ml
100mL; 250mL
VM - Veterinary Medicine
PIGS | BOAR | GILT | PIGLET | SOW | SWINE
IMMUNOTHERAPY
MYCOPLASMA HYOPNEUMONIAE | REDUCTION OF LUNG LESIONS | RESPIRATORY DISEASE | SWINE ENZOOTIC PNEUMONIA
Poison schedule: 0; Withholding period: ; Host/pest details: PIGS: [MYCOPLASMA HYOPNEUMONIAE]; For the vaccination of the healthy pigs against clinical signs caused by mycoplasma hyopneumoniae by reducing of lung lesions caused by this disease organism. Aid in the reduction of mycoplasma induced respiratory disease and growth suppression.Do not vaccinate sick animals
Stopped
2018-06-30
Virbac (Australia) Pty Limited Page 1 of 2 Product Name: Suvaxyn M.Hyo Vaccine APVMA Number: 50420/60539 Version Date: 27 Sep2013 Pack sizes: 100 ml (SO doses) 250 ml (125 Doses) TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPs) (Veterinary Products) Select appropriate: IJ New Product (include all applicable RLPs) OR ./ Variation (highlight instructions that are being varied). Approval no. of label being varied: ................ . Signal heading: FOR ANIMAL TREATMENT ONLY. Product name: SUVAXYN M. Hyo VACCINE Active constituentls: A liquid adjuvanted bacterin consisting of inactivated Mycoplasma hyopneumoniae (RP 2'1.0). Contains thiomersal 0.1 mg /mL as a preservative. Statement of claims: For the vaccination of healthy pigs against clinical signs caused by Mycoplasma hyopneumoniae by the reduction of lung lesions caused by this disease organism. Aids in the reduction of mycoplasma induced respiratory disease and growth suppression. Net contents: 100 mL(50 doses)/250 mL(125 doses) Directions for Use DIRECTIONS FOR USE: Heading: Restraints: N/A Contraindications: Do not vaccinate sick animals Precautions: Allergic reactions in pigs although rare, may occur. Side effects: N/A Dosage & Shake well before use. Use entire contents within 24 hours administration: Dose: 2 mL intramuscularly using aseptic technique. Sucking pigs: Inject 2 mL at 7 to 10 days of age or prior to weaning. Repeat with second dose 2 to 3 weeks after first vaccination. Introduced growers and breeders: Inject 2 mL at time of arrival and repeat vaccination 2 to 3 weeks later. General directions: Caution: avoid carcass damage + 1. Sterilise all injection apparatus by boiling before use. Avoid use of strong disinfectants on apparatus. 2. Maintain cleanliness at all times. RLP 3. Keep needles sharp and clean. ·-,IJProved 4. Use needles of appropriate gauge and length. 5. As far as possible avoid injection of animals during wet weather or under • VIRBAC (AUSTRALIA) PTY LIMITED Page 2 of 2 PRODUCT NAME: SUVAXYN M.HYO VACCINE APVMA Number: 50420/60539 Прочитать полный документ
VIRBAC (AUSTRALIA) PTY. LTD. MATERIAL SAFETY DATA SHEET Product Name: Suvaxyn ® M.Hyo Vaccine PAGE: 1 OF 5 DATE OF ISSUE 1 FEBRUARY 2010 EMERGENCY: VIRBAC: 02 9772 9772 OR 1800 242 100 (BUSINESS HOURS ONLY) POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY COMPANY: VIRBAC (AUSTRALIA) PTY. LTD ABN 77 003 268 871 ADDRESS 361 Horsley Rd, Milperra, NSW 2214, Australia Locked Bag 6000, Milperra Business Centre, NSW 1891, Australia TELEPHONE: (02) 9772 9772 or 1800 242 100 FAX: (02) 9772 9773 EMERGENCY PHONE As above during business hours; answering machine after hours SUBSTANCE: Water suspension of _Mycoplasma hyopneumoniae_. TRADE NAME: SUVAXYN ® M.HYO VACCINE APVMA CODE: 50420 PRODUCT USE: Vaccination of healthy pigs against clinical signs caused by _Mycoplasma _ _hyopneumoniae_. CREATION DATE: FEBRUARY, 2010 REVISION DATE: DECEMBER, 2010 SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of ASCC. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: None allocated. ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated EMERGENCY OVERVIEW PHYSICAL DESCRIPTION & COLOUR : Red coloured aqueous suspension . ODOUR: No data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. POTENTIAL HEALTH EFFECTS NOTE: DIFFERENT HAZARD ASSESSMENT CRITERIA OF ASCC AND TGA MAY RESULT IN SEEMING INCONSISTENCIES BETWEEN MSDS AND LABEL. EFFECTS DESCRIBED IN THIS MSDS RELATE TO SHORT TERM EMERGENCY SITUATIONS, SUCH AS ACCIDENTS AND SPILLS WITH THE POTENTIAL FOR GROSS OVEREXPOSURE, AND TO LONG TERM INDUSTRIAL AND MANUFACTURING EXPOSURE. SEE PRODUCT LABEL FOR ASSESSMENT OF HEALTH EFFECTS OF EXPOSURE DURING NORMAL ON-FARM Прочитать полный документ